e-learning
resources
Paris 2018
Sunday, 16.09.2018
Biomarkers for evaluating COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?
H. Yakar (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey)
Source:
International Congress 2018 – Biomarkers for evaluating COPD
Session:
Biomarkers for evaluating COPD
Session type:
Thematic Poster
Number:
1076
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Yakar (Istanbul, Turkey), A. Kanbay (Istanbul, Turkey), E. Ceylan (Istanbul, Turkey). Could eosinophil / neutrophil ratio be used to determine treatment in COPD patients?. 1076
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients?
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Analysis of IMPACT: is one blood eosinophil count measurement sufficient to predict ICS treatment response in COPD?
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
LSC - 2019 - Assessment of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio as biomarkers of steroid resistance in patients with COPD
Source: International Congress 2019 – Novel molecular pathways in lung cancer and COPD
Year: 2019
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
The eosinophil cationic protein/eosinophil count ratio as a marker of asthma in children
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002
Changes in eosinophil count and C reactive protein following treatment with mebendazole in patients with Toxocara-associated asthma
Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections
Year: 2010
Importance of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in COPD exacerbations
Source: International Congress 2017 – COPD and weaning
Year: 2017
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute exacerbation of COPD.
Source: International Congress 2017 – Highlights on clinical problems in COPD
Year: 2017
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Definition of COPD phenotype depending on eosinophil count
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015
The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Lymphocyte-to-segmentonuclear neutrophil ratio in patients with pulmonary tuberculosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Can blood eosinophils predict sputum eosinophils in stable COPD?
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept